Real world performance of inactivated SARS-CoV-2 vaccine (CoronaVac) against infection, hospitalization and death due to COVID-19 in adult population in Indonesia

Anton Suryatma, Raras Anasi, Miko Hananto, Asep Hermawan, Ririn Ramadhany, Irene Lorinda Indalao, Agustiningsih Agustiningsih, Ely Hujjatul Fikriyah, Kristina Lumban Tobing, Teti Tejayanti, Rustika Rustika, Pandji Wibawa Dhewantara
doi: https://doi.org/10.1101/2022.02.02.22270351

Data Availability

The datasets used and/or analyzed during the current study are protected by the Ministry of Health of Indonesia and are unsuitable for public sharing. Interested parties can apply for the data by contacting the data center of the Ministry of Health of Indonesia. All data generated or analyzed during this study are included in this published article (and its Supplementary information files). Aggregate data on vaccination and COVID-19 incidence are publicly available at https://vaksin.kemkes.go.id/#/vaccines

Back to top
Posted March 11, 2022.
Download PDF
Data/Code
Email
Real world performance of inactivated SARS-CoV-2 vaccine (CoronaVac) against infection, hospitalization and death due to COVID-19 in adult population in Indonesia
Anton Suryatma, Raras Anasi, Miko Hananto, Asep Hermawan, Ririn Ramadhany, Irene Lorinda Indalao, Agustiningsih Agustiningsih, Ely Hujjatul Fikriyah, Kristina Lumban Tobing, Teti Tejayanti, Rustika Rustika, Pandji Wibawa Dhewantara
medRxiv 2022.02.02.22270351; doi: https://doi.org/10.1101/2022.02.02.22270351
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area